678 tracked 13F filers disclose a position in MRNA as of the latest SEC 13F filings, a combined $15.1B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | $2.3B | 45.7M | ▲+63% Added · +17.6M sh | Q1 2026 | |
| 2 | BlackRock, Inc. | $1.5B | 29.6M | ▼−8.8% Reduced · −2.9M sh | Q1 2026 | |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | $1.2B | 22.9M | →First observed position No prior filed position | Q1 2026 | |
| 4 | BAILLIE GIFFORD & CO | $1.0B | 20.0M | ▼−2.9% Reduced · −595K sh | Q1 2026 | |
| 5 | STATE STREET CORP | $1.1B | 15.7M | ▲+5.8% Added · +865K sh | Q2 2026 | |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | $793.3M | 15.6M | →First observed position No prior filed position | Q1 2026 | |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | $678.8M | 9.7M | ▲+2.9% Added · +275K sh | Q2 2026 | |
| 8 | TWO SIGMA INVESTMENTS, LP | $461.6M | 9.1M | ▲+24% Added · +1.7M sh | Q1 2026 | |
| 9 | MORGAN STANLEY | $430.3M | 8.5M | ▼−4.5% Reduced · −399K sh | Q1 2026 | |
| 10 | Theleme Partners LLP | $564.3M | 8.1M | ▲+0.1% Added · +9K sh | Q2 2026 | |
| 11 | GOLDMAN SACHS GROUP INC | $335.5M | 6.6M | ▲+67% Added · +2.7M sh | Q1 2026 | |
| 12 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $240.5M | 4.7M | ▲+2.4% Added · +113K sh | Q1 2026 | |
| 13 | Flagship Pioneering, LLC | $235.3M | 4.6M | —Held | Q1 2026 | |
| 14 | UBS Group AG | $223.9M | 4.4M | ▲+7.8% Added · +321K sh | Q1 2026 | |
| 15 | BNP PARIBAS FINANCIAL MARKETS | $219.3M | 4.3M | ▲+4.0% Added · +165K sh | Q1 2026 | |
| 16 | Alyeska Investment Group, L.P. | $205.8M | 4.1M | ▲+25% Added · +823K sh | Q1 2026 | |
| 17 | NORTHERN TRUST CORP | $150.0M | 3.0M | ▼−1.7% Reduced · −51K sh | Q1 2026 | |
| 18 | NORGES BANK | $79.7M | 2.7M | ▼−21% Reduced · −737K sh | Q4 2025 | |
| 19 | BANQUE PICTET & CIE SA | $189.0M | 2.7M | ▼−1.8% Reduced · −49K sh | Q2 2026 | |
| 20 | FIRST TRUST ADVISORS LP | $121.5M | 2.4M | ▲+59% Added · +891K sh | Q1 2026 | |
| 21 | Merck & Co., Inc. | $161.6M | 2.3M | —Held | Q2 2026 | |
| 22 | DIMENSIONAL FUND ADVISORS LP | $108.2M | 2.1M | ▲+19% Added · +343K sh | Q1 2026 | |
| 23 | FEDERATED HERMES, INC. | $100.4M | 2.0M | ▼−9.2% Reduced · −201K sh | Q1 2026 | |
| 24 | VANGUARD FIDUCIARY TRUST CO | $99.9M | 2.0M | →First observed position No prior filed position | Q1 2026 | |
| 25 | NATIONAL BANK OF CANADA /FI/ | $92.3M | 1.8M | ▼−16% Reduced · −339K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 1 fund opened a new position in MRNA and 29 added to an existing one, while 15 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| MICROSOFT CORPMSFT | 389 funds | $261.6B |
| NVIDIA CORPNVDA | 388 funds | $389.6B |
| AMAZON.COM INCAMZN | 388 funds | $200.1B |
| APPLE INCAAPL | 385 funds | $292.9B |
| META PLATFORMS INC-CLASS AMETA | 384 funds | $116.5B |
| ALPHABET INC-CL AGOOGL | 380 funds | $159.5B |
| ALPHABET INC-CL CGOOG | 378 funds | $128.8B |
| BROADCOM INCAVGO | 377 funds | $151.5B |
| ELI LILLY & COLLY | 375 funds | $76.7B |
| JPMORGAN CHASE & COJPM | 375 funds | $61.9B |
| MERCK & CO. INC.MRK | 373 funds | $27.7B |
| ADVANCED MICRO DEVICESAMD | 369 funds | $39.5B |
Ranked by how many of MRNA's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 5, 2026 | Bancel Stephane | Chief Executive Officer, Director | Sell (S) | 147K | $8.3M |
| Aug 5, 2026 | Bancel Stephane | Chief Executive Officer, Director | Sell (S) | 125K | $7.1M |
| Aug 5, 2026 | Bancel Stephane | Chief Executive Officer, Director | Sell (S) | 40K | $2.3M |
| Aug 5, 2026 | Bancel Stephane | Chief Executive Officer, Director | Sell (S) | 187K | $11.0M |
| Jul 15, 2026 | Hoge Stephen | President | Sell (S) | 53K | $3.6M |
| Jun 15, 2026 | Hoge Stephen | President | Sell (S) | 53K | $2.7M |
| Jun 4, 2026 | Klinger Shannon Thyme | Chief Legal Officer | Sell (S) | 3K | $174K |
| May 21, 2026 | AFEYAN NOUBAR | Director | Sell (S) | 9K | $434K |
| May 15, 2026 | Hoge Stephen | President | Sell (S) | 53K | $2.6M |
| May 1, 2026 | Hussain Abbas | Director | Sell (S) | 6K | $265K |
| Mar 2, 2026 | Klinger Shannon Thyme | Chief Legal Officer | Sell (S) | 14K | $726K |
| Feb 23, 2026 | Hoge Stephen | President | Sell (S) | 160K | $7.8M |
Connected entities for MRNA
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/MRNA/capital-change-brief"
Use Arkolith's capital_change_brief for MRNA. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for MRNA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.